Nano Mobile Healthcare Inc. (VNTH)

Overview

Nano Mobile Healthcare, Inc. is a pioneering mobile health technology company based in Boston, Massachusetts, United States. Initially founded under the name Vantage mHealthcare, Inc., the company underwent a strategic rebranding to Nano Mobile Healthcare, Inc. in September 2015. Since its incorporation in 2010, Nano Mobile Healthcare, Inc. has been at the forefront of developing innovative, personalized, and point-of-care screening solutions. These solutions leverage cutting-edge chemical sensing methodologies tailored for the mobile health market. Through a strategic partnership with Theranostics Laboratory, a renowned translational research company, Nano Mobile Healthcare, Inc. is positioned to enhance its research capabilities and market presence. As a subsidiary of Nanobeak, Inc., the company benefits from additional resources and technological synergy, reinforcing its mission to transform the landscape of mobile health technologies.

Products and Services

Nano Mobile Healthcare, Inc. specializes in designing and offering a range of products and services committed to revolutionizing the healthcare landscape through mobile technology. Highlighting the company's focus on specificity, convenience, and the need for timely healthcare solutions, its portfolio features:

• Personalized Screening Applications: Utilizing proprietary chemical sensing methods, these applications enable users to perform health screenings directly from their mobile devices. By catering to individual health concerns and preferences, these applications empower users with valuable insights into their health status in real-time, fostering a proactive approach to healthcare management.
• Point-of-Care Screening Solutions: Focused on delivering instant diagnostic capabilities, Nano Mobile Healthcare, Inc.’s point-of-care solutions are designed for both healthcare professionals and consumers. These solutions are pivotal in environments where rapid decision-making based on accurate health data is crucial. By streamlining the diagnostic process, these screening solutions significantly reduce the time from assessment to intervention, enhancing the efficacy of healthcare delivery.